Cholecystokinin inhibits binding of substance P to pancreatic acinar cells.
L
L
Sjödin
D000818:Animals; D001839:Bombesin / Q000494:pharmacology; D002478:Cells, Cultured; D002108:Ceruletide / Q000494:pharmacology; D005749:Gastric Inhibitory Polypeptide / Q000494:pharmacology; D005755:Gastrins / Q000494:pharmacology*; D006168:Guinea Pigs; D007328:Insulin / Q000494:pharmacology; D010179:Pancreas / Q000166:cytology / Q000378:metabolism*; D018040:Receptors, Neurokinin-1; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012633:Secretin / Q000494:pharmacology; D013373:Substance P / Q000378:metabolism* / Q000494:pharmacology; D013758:Tetragastrin / Q000494:pharmacology*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D005755:Gastrins; D007328:Insulin; D018040:Receptors, Neurokinin-1; D017981:Receptors, Neurotransmitter; D013758:Tetragastrin; D012633:Secretin; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D005749:Gastric Inhibitory Polypeptide; D002108:Ceruletide; D001839:Bombesin